Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTate & Lyle Regulatory News (TATE)

Share Price Information for Tate & Lyle (TATE)

Share Price is delayed by 15 minutes
Get Live Data
505.00    0.00 (0.00%)
Bid:
0.00
Ask:
540.00
Spread: 35.00 (6.931%)
Market Cap: £2.23b
TATE Live PriceLast checked at - London Stock Exchange

Intraday Tate & Lyle Share Chart

Trading Statement

23 Jul 2020 07:00

RNS Number : 8095T
Tate & Lyle PLC
23 July 2020
 

23 July 2020 - Tate & Lyle PLC

 

 

TRADING STATEMENT

 

Tate & Lyle issues the following trading statement for the three months to 30 June 2020.

 

As anticipated in our trading update on 4 May 2020 and in our full-year results statement on 21 May 2020, the Group's performance in the first quarter reflected the impact of lockdowns on out-of-home consumption in North America and Europe, partially offset by resilience from in-home consumption. Having seen fluctuating demand patterns in April and May, demand improved in both divisions in June as lockdowns started to ease. The full extent of the pandemic's impact still remains unclear.

 

Our response to Covid-19 has successfully focused on ensuring we look after the health, safety and wellbeing of our colleagues, their families and the local communities in which we operate; and to work closely with our customers to play our part in supporting the food supply chain with all our manufacturing facilities remaining fully operational in the quarter.

 

Three months ended 30 June 2020

Volume change

Revenue growth*

 

Food & Beverage Solutions

 

(2%)

 

+1% 

Sucralose

(2%)

(1%)

Primary Products

(12%)

(9%)

 

 

 

Group

 

(5%)

 

* Growth in constant currency

 

Food & Beverage Solutions

Revenue was £232 million, 1% higher benefiting from good price and mix management and 9% growth in New Products[1] revenue. Volume was 2% lower as reduced demand for ingredients used in food and drink consumed out-of-home (representing 15% to 25% of revenue) outweighed stronger demand for packaged and shelf-stable foods for consumption in-home.

 

In North America, revenue for the quarter was 2% lower due to reduced demand for out-of-home consumption particularly in the food service sector. North America returned to revenue growth in June as lockdown restrictions eased. In Europe, Middle East and Africa revenue was in line with the comparative period reflecting solid demand for in-home consumption. In Asia Pacific and Latin America revenue was 8% higher reflecting good revenue growth in Asia Pacific as China emerged from lockdown, while in Latin America revenue grew modestly, slowing as the quarter progressed and the region went into lockdown.

 

Sucralose

Revenue was £39 million, 1% lower reflecting softer demand for products consumed out-of-home, particularly beverages.

 

Primary Products

Revenue was £420 million, 9% lower. North American bulk sweetener volume was 12% lower reflecting reduced out-of-home consumption (representing around 30% of sweetener consumption) with demand recovering sequentially during the quarter as some US states began to ease lockdown restrictions. Industrial starch volume was 16% lower as the paper industry took actions to reduce capacity temporarily with many schools and offices still closed.

 

Reducing costs and preserving cash

The financial impact of lower demand was partially mitigated by actions taken to reduce costs including freezing salary increases and recruitment and significantly reducing discretionary costs. Procedures were also put in place to preserve cash through re-prioritising capital commitments and a rigorous approach to managing working capital. No employees have been furloughed and no government aid has been sought.

 

Strong balance sheet

Our balance sheet is strong with net debt at 30 June 2020 of £384 million, £67 million lower than at 31 March 2020 reflecting seasonal improvement and good cash management.

 

Nick Hampton, Chief Executive said:

"As expected, the first quarter presented many challenges and I am very proud of the way we are navigating the impact of Covid-19. We are encouraged by the improvement in demand we saw in June and the continued strategic progress we are making, with new product revenue growing 9% in the quarter. Our new business pipeline is healthy, we continue to find creative ways to use technology to support and connect with our customers, and all our manufacturing facilities remain fully operational.

 

The fundamentals of our business are sound. Demand for ingredients and solutions which enable consumers to enjoy healthier and tastier food and drink is strong, and we have the portfolio of products and technical expertise to help our customers deliver on these trends.

 

Looking ahead, our priorities are clear - to look after our people and communities, strengthen our relationships with customers, continue to progress our strategy and maintain our financial strength. I am confident that our future prospects remain strong."

 

 

 

For more information contact Tate & Lyle PLC:

Christopher Marsh, VP, Investor Relations

Tel: Mobile: +44 (0) 7796 192 688

 

Nick Hasell, FTI Consulting (Media)

Tel: Mobile: +44 (0) 7825 523 383

 

 

About Tate & Lyle:

Tate & Lyle is a global provider of solutions and ingredients for food, beverage and industrial markets.

Tate & Lyle operates through two global divisions, Food & Beverage Solutions and Primary Products, supported by the Innovation and Commercial Development and Global Operations teams. Food & Beverage Solutions is focused on growth by building leading positions globally in the categories of beverages, dairy, and soups, sauces and dressings. Primary Products is focused on delivering steady earnings and generating cash.

Food & Beverage Solutions consists of: Texturants, including speciality starches; Sweeteners, including low- and no-calorie sweeteners; and a Health and Wellness portfolio comprising mainly speciality fibres; and Stabilisers and Functional Systems, which are bespoke ingredient blends that ensure foods retain their structure.

Primary Products consists of high-volume sweeteners, industrial starches and fermentation products (primarily acidulants). It also sells co-products from the corn milling process as animal nutrition.

Tate & Lyle is listed on the London Stock Exchange under the symbol TATE.L. American Depositary Receipts trade under TATYY. In the year to 31 March 2020, Tate & Lyle revenue totalled £2.9 billion. For more information, please visit http://www.tateandlyle.com or follow Tate & Lyle on Twitter or LinkedIn.

 

 

 

[1] New Products are products launched in the last seven years

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
TSTKKBBKABKDFOB
Date   Source Headline
3rd Jun 20263:20 pmRNSForm 8.3 - Tate & Lyle plc
3rd Jun 20263:16 pmRNSForm 8.3 TATE & LYLE PLC
3rd Jun 20262:25 pmRNSForm 8.5 (EPT/NON-RI) - TATE & LYLE PLC
3rd Jun 20261:56 pmEQSForm 8.3 - The Vanguard Group, Inc.: Tate & Lyle plc
3rd Jun 20261:56 pmRNSForm 8.3 - Tate & Lyle plc
3rd Jun 20261:40 pmRNSForm 8.3 - Tate & Lyle plc
3rd Jun 202611:57 amRNSForm 8.5 (EPT/RI) - TATE & LYLE PLC
3rd Jun 202611:15 amRNSForm 8.5 (EPT/NON-RI)-Tate & Lyle plc
3rd Jun 202611:11 amRNSForm 8.5 (EPT/NON-RI)-Tate & Lyle plc
3rd Jun 202611:04 amRNSForm 8.5 (EPT/RI)-Tate & Lyle plc
3rd Jun 202611:02 amRNS20260602_TATE & LYLE_8.5 EPT RI_UK_MLI
3rd Jun 202610:41 amRNSForm 8.3 - Tate & Lyle PLC
3rd Jun 202610:24 amRNSForm 8.5 (EPT/RI)
2nd Jun 20265:13 pmRNSForm 8.5 (EPT/RI)-Tate & Lyle plc Amend
2nd Jun 20265:00 pmRNSForm 8.5 (EPT/NON-RI) - TATE & LYLE PLC
2nd Jun 20264:33 pmRNSForm 8.5 (EPT/RI) - TATE & LYLE PLC
2nd Jun 20263:20 pmRNSForm 8.3 - Tate & Lyle plc
2nd Jun 20263:00 pmRNSForm 8.3 TATE & LYLE PLC
2nd Jun 20262:47 pmRNSForm 8.5 (EPT/RI)-Amend Tate & Lyle PLC
2nd Jun 20262:30 pmRNSAnnual Financial Report and Notice of Meeting 2026
2nd Jun 202612:33 pmRNSForm 8.3 - Tate & Lyle PLC
2nd Jun 202611:47 amRNSForm 8.5 (EPT/NON-RI)-Tate & Lyle plc
2nd Jun 202611:45 amRNS20260601_TATE & LYLE_8.5 EPT RI_UK_MLI
2nd Jun 202611:44 amRNSForm 8.5 (EPT/NON-RI)-Tate & Lyle plc
2nd Jun 202611:32 amRNSForm 8.5 (EPT/RI)-Tate & Lyle plc
2nd Jun 202611:04 amRNSForm 8.5 (EPT/RI)-Amend Tate & Lyle PLC
2nd Jun 20268:42 amRNSForm 8.5 (EPT/RI)
1st Jun 20265:27 pmRNS20260526_TATE & LYLE_8.5 EPT RI_UK_MLI_replacement
1st Jun 20265:22 pmRNS20260526_TATELYLE8.5 EPT NON-RI BOFASE_replacement
1st Jun 20265:17 pmRNS20260522_TATE & LYLE_8.5 EPT RI_UK_MLI_replacement
1st Jun 20265:10 pmRNSForm 8.5 (EPT/RI)-Tate & Lyle plc Amend
1st Jun 20264:55 pmRNS20260521_TATE & LYLE_8.5 EPT RI_UK_MLI_replacement
1st Jun 20263:35 pmRNSDirector/PDMR Shareholding
1st Jun 20263:30 pmRNSForm 8.3 - Tate & Lyle plc
1st Jun 20263:20 pmRNSForm 8.3 TATE & LYLE PLC
1st Jun 20263:20 pmRNSForm 8.3 - Tate & Lyle plc
1st Jun 20262:26 pmPRNInvesco Ltd: Form 8.3 - Tate & Lyle PLC; Public dealing disclosure
1st Jun 20262:17 pmRNSForm 8.3 - Tate & Lyle plc
1st Jun 20262:12 pmRNSForm 8.3 - Tate & Lyle plc
1st Jun 202611:45 amRNSForm 8.5 (EPT/RI) - TATE & LYLE PLC
1st Jun 202611:37 amRNSForm 8.5 (EPT/NON-RI) - TATE & LYLE PLC
1st Jun 202611:24 amRNSForm 8.5 (EPT/NON-RI)-Tate & Lyle plc
1st Jun 202611:20 amRNSForm 8.5 (EPT/RI)-Tate & Lyle plc
1st Jun 202611:11 amBUSForm 8.3 - Tate & Lyle PLC
1st Jun 202611:00 amRNSTotal Voting Rights
1st Jun 202610:52 amRNSForm 8.3 – Tate & Lyle plc
1st Jun 202610:49 amRNS20260529_TATE & LYLE_8.5 EPT NON-RI_UK_BOFASE
1st Jun 202610:47 amRNS20260529_TATE & LYLE_8.5 EPT RI_UK_MLI
1st Jun 202610:29 amRNSForm 8.3 - Tate & Lyle PLC
1st Jun 20268:48 amRNSForm 8.5 (EPT/RI)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.